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ABSTRACT
Dietary guidelines commonly recommend that children aged >2 y consume reduced-fat dairy products rather than regular- or whole-fat dairy. In
adults, most studies have not found the consumption of whole-fat dairy products to be associated with increased cardiometabolic or adiposity risk.
Associations in children could diﬀer due to growth and development. We systematically reviewed the literature in indexed, peer-reviewed journals
to summarize pediatric studies (children aged from 2 to 18 y) assessing associations between whole- and reduced-fat dairy intake and measures of
adiposity as well as biomarkers of cardiometabolic disease risk, including the serum lipid proﬁle, blood pressure, low-grade chronic inﬂammation,
oxidative stress, and measures of glucose homeostasis. For the purposes of this review, a “whole-fat” dairy product was deﬁned as a product with
the natural fat content, whereas a “reduced-fat” dairy product was deﬁned as a product with some or all of the fat removed (including “low-fat” and
“skim” versions). A total of 29 journal articles met our criteria for inclusion. The majority were conducted in the United States and were prospective
or cross-sectional observational studies, with only 1 randomized controlled trial. Studies were consistent in reporting that whole-fat dairy products
were not associated with increased measures of weight gain or adiposity. Most evidence indicated that consumption of whole-fat dairy was not
associated with increased cardiometabolic risk, although a change from whole-fat to reduced-fat dairy improved outcomes for some risk factors in
1 study. Taken as a whole, the limited literature in this ﬁeld is not consistent with dietary guidelines recommending that children consume preferably
reduced-fat dairy products. High-quality randomized controlled trials in children that directly compare the eﬀects of whole-fat compared with
reduced-fat dairy intake on measures of adiposity or biomarkers of cardiometabolic disease risk are needed to provide better quality evidence in
this area. Adv Nutr 2020;00:1–23.
Keywords: dairy, low-fat, regular-fat, skim milk, whole milk, children, pediatric, overweight, cholesterol

Introduction
Dietary guidelines in the United States, Australia, the
United Kingdom, and other countries recommend that adults
and children consume predominantly reduced-fat, rather
than whole-fat (also known as full-fat or regular-fat) dairy
products (1–5). Reduced-fat dairy products are traditionally
recommended over whole-fat dairy products due to their
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Author disclosures: MK has received reimbursement for travel and honoraria for speaking as
well as a research grant from dairy-related organizations. TAOS has previously received a
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Address correspondence to TAOS (e-mail: t.osullivan@ecu.edu.au).
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lower energy and saturated fat content, which is thought to
limit the risk of excessive energy intake, weight gain, and
cardiometabolic disease (6).
Although the hypothesis that removing fat from dairy
foods could benefit body weight and cardiometabolic risk
does have theoretical plausibility, it does not seem to be supported by currently available data. Consumption of wholefat dairy products is not associated with the development
of obesity or cardiometabolic disease in adults, and could
even be beneficial (7–9). A review of observational studies
in adults found that dairy fat consumption is not associated
with an increased risk of weight gain, type 2 diabetes
mellitus, or cardiovascular disease (10). Another review
of observational studies found that circulating and tissue
biomarkers of habitual dairy fat intake (pentadecanoic acid,
15:0, and heptadecanoic acid, 17:0) were not associated with
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differing needs in growth and development. It is valuable to
consider both adiposity and cardiometabolic factors, because
both these aspects have important and often interlinking
long-term health effects.
The aim of this article is to comprehensively evaluate
the existing literature reporting associations between wholefat dairy consumption, including comparison with reducedfat dairy where available, and measures of adiposity and
cardiometabolic risk factors in children. Summarizing the
literature in this area will be informative for upcoming
dietary guideline revisions, and will also assist in identifying gaps to plan future research. We investigated dairy
with differing fat content along with dairy fat and associated biomarkers, to help account for inherent factors
in dairy products that might be responsible for health
outcomes (20).
Our research questions were:
1) In children, is consumption of whole-fat dairy products or
dairy fat associated with higher measures of adiposity? Do
associations differ for reduced-fat dairy intake?
2) In children, is consumption of whole-fat dairy products or
dairy fat associated with increased cardiometabolic risk?
Do associations differ for reduced-fat dairy intake?

Methods
This systematic review was conducted in accordance with
the Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) statement. For the purposes of this
review, a “whole-fat” dairy product is defined as a product
with the natural fat content, whereas a “reduced-fat” dairy
product is defined as a product that has had some or all of
the fat removed (including “low-fat” and “skim” versions).
One study in this review (21) also included dairy foods that
are naturally low in fat, such as cottage cheese, in the low-fat
dairy category.
Search process
Searches used combinations of the search terms: Dairy OR
milk OR cheese OR yogurt OR yoghurt; AND child OR children OR adolescence OR adolescent OR school OR boy OR
girl OR teenage OR pediatric OR paediatric OR preschool OR
youth; AND cholesterol OR LDL OR HDL OR triglycerides
OR insulin OR glucose OR metabolic syndrome OR MetS OR
insulin resistance OR insulin sensitivity OR glucose tolerance
OR glucose intolerance OR cardiometabolic OR cardio OR
metabolic OR obesity OR obese OR overweight OR body
fat OR waist OR waist-to-height OR body mass index OR
growth OR BMI OR weight OR blood pressure OR arterial
pressure.
Studies were identified in peer-reviewed journals indexed
by the databases MEDLINE (22), PubMed (23), the Cochrane
Library (24), and Embase (25) up to 30 June 2019. In
addition, Google Scholar (26) was searched for relevant
studies.
The title and abstracts were assessed by 2 researchers
(TAOS and KAS) for general relevance. The full-text versions
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cardiovascular disease-related outcomes or type 2 diabetes
mellitus, although the authors noted limitations of these
biomarkers including uncertainty of dietary origins and
endogenous metabolism (11). Additionally, higher intakes
of whole-fat dairy foods were not associated with increased
risk of mortality in a meta-analysis (12). These results are
supported by the large, multinational Prospective Urban
Rural Epidemiology (PURE) study, which found that higher
intake of dairy fat was not associated with increased risk of
total mortality or major cardiovascular disease (13).
In adult populations, emerging evidence is challenging
the long-standing belief that consumption of whole-fat dairy
products should be avoided in favor of lower-fat varieties.
Despite whole-fat dairy foods being more energy dense (i.e.,
more energy per gram consumed), it is unclear whether
whole-fat dairy foods are less satiating per calorie consumed.
It is also possible that the combination of numerous unique
fatty acids in dairy fat, including short-chain or branchedchain fatty acids, as well as conjugated linoleic acids and
trans-palmitoleic acid, could exert beneficial hormone-like
effects (14). In addition, milk fat globule membrane and
bioactive peptides from dairy show some potential to benefit
health, although more research is needed (15).
Consumption of dairy products, particularly milk, is
generally popular in children. Commonly considered to
be an important food group as part of a balanced diet,
dairy products are a good dietary source of nutrients for
healthy development, including protein, calcium, potassium,
phosphorus, and several vitamins. Two meta-analyses of
observational studies published in 2016 both concluded that
total dairy consumption was inversely associated with risk
of overweight and obesity in children (16, 17). Likewise, a
review of dairy consumption in children and adolescents,
with a focus on results from the Healthy Lifestyle in Europe
by Nutrition in Adolescence (HELENA) study, found that
higher consumption of milk and yogurt was associated with
improved cardiovascular risk factors (18). Similarly, a nonsystematic critical review concluded that milk and other
dairy products were consistently not associated, or inversely
associated, with indicators of adiposity in children (19). The
authors also noted that adjustment for energy intake tended
to neutralize inverse associations.
However, there is a paucity of research specifically focused
on potential differential effects of whole-fat compared with
reduced-fat dairy intake in children (17). Although the focus
of the reviews was on total dairy rather than dairy fat, studies
that were noted as evaluating both whole-fat and reducedfat dairy products suggested the relation between dairy and
adiposity was unlikely to vary according to fat type.
To our knowledge, there have been no published systematic reviews investigating associations between dairy fat
and types of dairy products with measures of adiposity and
cardiometabolic health in pediatric populations. Given the
changing attitudes toward whole-fat dairy consumption in
adults, it is timely to investigate this concept in children.
Consumption of dairy products might result in different
health effects in children compared with adults, due to

Eligibility criteria
Studies were eligible for inclusion in this review if:
1) Subjects in the study were between 2 and 18 y of age, or
(for prospective studies) data from ages 2 to 18 y were
reported.
2) Subjects were generally healthy/representative of the general population (including overweight/obese children).
3) The exposure included dairy fat intake or a dairy fat
biomarker, or associations reported separately for wholefat and reduced-fat dairy.
4) Outcomes reported included ≥1 measure of adiposity
(including BMI, body composition, body weight, BMI
categories) or cardiometabolic health (including serum
lipids, insulin sensitivity, glucose tolerance, low-grade
chronic inflammation, blood pressure, or metabolic syndrome).
5) Dairy intake was restricted to products derived from
ruminant animals—studies investigating breastmilk were
not included. Studies investigating specific fortified dairy
products, including formula or specific probiotic or fiberenriched dairy products, were not included.
6) No dietary changes other than dairy (in intervention
studies), and no complex exposures including factors
other than dairy (observational studies).
Cardiometabolic health measures
We included studies reporting data on a standard serum lipid
profile, including total cholesterol (TC), LDL cholesterol,
HDL cholesterol, and triglycerides. Although dietary
recommendations around reducing saturated fat from
dairy have focused largely on benefits to LDL cholesterol,
several studies, including the Framingham Heart Study,
have demonstrated that lipid ratios are better indicators
of cardiovascular risk than LDL cholesterol alone (27–
29). LDL cholesterol is most commonly calculated
based on TC, HDL cholesterol, and triglyceride values.
TC:HDL cholesterol can therefore be considered to provide
information in a more straightforward manner, because
both variables are measured directly (30). Furthermore,
lipid ratios are preferred over non-HDL cholesterol values
for predicting chronic disease risk, including coronary
heart disease (31) and nonalcoholic fatty liver disease
(32). In addition, consideration of the apoB to apoA1 ratio could also be important. ApoB is the major
protein in LDL cholesterol particles, whereas apoA-1 is
the major protein in HDL cholesterol particles. The ratio

is considered to represent the balance between atherogenic
and antiatherogenic particles. This ratio is closely related
to different cardiovascular events in prospective studies
(33), and is considered better than LDL cholesterol at
predicting cardiovascular risk (34). Although full details are
given in the tables, for the discussion we chose to focus on
the TC:HDL cholesterol ratio as well as the apoB:apoA1 ratio where available, rather than individual lipid
measures (35).
Both fasting glucose and insulin, and derived measures,
as well as glycated hemoglobin (HbA1c), were selected as
biomarkers of glucose metabolism in this review. Insulin is
an important regulator of glucose metabolism. The HOMAIR is a surrogate measure of insulin resistance using both
fasting glucose and fasting insulin. It is considered to be a
robust clinical and epidemiological tool that compares well
with more invasive models of insulin resistance (36). HbA1c
refers to the percentage of hemoglobin that is glycated,
and represents the average amount of glucose present in
the blood over the prior 3 mo. Higher values indicate
poorer glycemic control. Assessment of glucose tolerance or
insulin sensitivity using oral or intravenous glucose tolerance
tests, or euglycemic-hyperinsulinemic clamps, was also
included.
We chose to include markers of low-grade chronic
systemic inflammation in our review, because chronic inflammation and activation of the immune system can be
involved in the pathogenesis of cardiovascular disease and
obesity-related insulin resistance (37, 38). C-reactive protein
(CRP) is an acute-phase protein commonly used to assess
systemic inflammation. Other common measures of lowgrade chronic inflammation include the proinflammatory
cytokines IL-6 and TNF-α, both of which are secreted by
activated proinflammatory leukocytes. Higher circulating
concentrations of CRP, IL-6, and TNF-α are thought to
indicate greater activation of proinflammatory pathways in
the body.
We also chose to include data on adiponectin, a fatderived hormone that acts as a messenger to communicate
between adipose tissue and other organs (39). Higher
concentrations are considered to be metabolically beneficial,
because adiponectin suppresses glucose production in the
liver and enhances fatty acid oxidation in skeletal muscle
(39). The production of adiponectin is directly suppressed by
inflammatory cytokines, such as TNF-α, and adiponectin can
therefore be thought of as an inverse, adipose tissue–specific
measure of inflammation.

Dairy biomarkers
Dairy fat intake biomarkers as an additional measure of
dietary exposure are useful to provide objective information
for nutrition research, particularly because misreporting of
diet is an important source of error (40). There is no 1
accepted biomarker for dairy fat—as the most complex of
natural fats, dairy fat is comprised of ∼400 different fatty
acids (41). We focused only on those that are most established
Whole- or reduced-fat dairy in children 3
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of the included articles were then examined against eligibility
criteria by the same researchers, conducted independently.
The reference lists of selected articles were hand searched
by 1 researcher (TAOS) for possible inclusion in the review.
These subsequently identified articles were assessed for
inclusion (by TAOS and KAS). Where opinions differed, final
decisions on inclusion were determined by consensus during
consultation with the supervising researcher (MK). There
were no restrictions on study design.

Idenﬁcaon

Records idenﬁed through
database searching
(n = 312)

Addional records idenﬁed
through other sources – Google
Scholar, citaon search
(n = 18)

Screening

Records screened by tle and
abstract
(n =238)

Included

Eligibility

Records excluded based on tle
and abstract
(n = 181)
Full-text arcles assessed
for eligibility
(n = 57)

Arcles included in
systemac review
(n = 29)

Full-text arcles excluded: not
reporng both reduced fat and
regular fat dairy, dairy fat, or
biomarkers; supplementaon or
enrichment of milk; use of breastmilk
or formula; dairy intervenon that
also included other diet changes;
reviews; subjects <2 y; reporng
populaon rather than individual
data; conference abstract only.
(n = 28)

FIGURE 1 Flowchart of studies included in the systematic review.

as biomarkers of dairy fat intake: pentadecanoic acid (15:0),
heptadecanoic acid (17:0), and trans-palmitoleic acid (trans16:1n–7) (42).

Data extraction
Information was extracted from included journals by
1 researcher (TAOS) and verified by another (KAS). Discrepancies in data extraction were discussed and resolved
by consensus with the supervising author (MK). Extracted
data included the authors, year of publication, study design,
aim of study, country, year of study, sex, age and number
of participants, dietary and outcome assessments, potential
confounding factors considered, results, and conclusions.
We decided not to perform a meta-analysis as part of this
review due to the variability in exposure categorization or
nature of intervention, subject characteristics, and methods
used within the research. As has been previously noted,
differential potential for residual confounding, variation in
types of dairy foods consumed, and location-based bovine
feeding practices (pasture or grain based) all limit the ability
to compare data from different studies directly (10).
4
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Risk of bias
Assessments of individual studies were completed by
2 researchers, in an independent manner, without knowing
the results of the other researcher. For the purposes of this
review, no sensitivity or subgroup analyses were planned;
however, publication bias was investigated by comparing
those published articles reporting statistically significant
results with those with insignificant results.

Results
Search results
A flowchart detailing the number of studies screened,
excluded, and included in the review is displayed in
Figure 1.
Included studies
A total of 29 journal articles met our criteria for inclusion
in this review, reporting data from 22 different observational
cohorts and 2 trials. Some examined measures of adiposity along with cardiometabolic outcomes, whereas others
focused on one or the other. For research examining adiposity measures, 20 journal articles reported on whole- and
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Records aer 92 duplicates removed
(n = 238)

Australian children 8.6 ± 3.0 y
(4–13 y), 40% F
n = 145
Consuming ≥2 svs/d of
whole-fat dairy at baseline

Subjects

ALSPAC
Bigornia et al., 2014 (46)
3-y follow-up

UK children, 11 ± 0.2 y at
baseline, 53% F
n = 2455

Mexican children from 13
boarding schools
11 ± 3 y (6–16 y),
(% F not speciﬁed)
n = 462
Usual consumers of whole-fat
dairy at baseline
OBSERVATIONAL: PROSPECTIVE (10 studies)
US children 9–14 y at baseline,
Growing Up Today
56% F
Berkey et al., 2005 (45)
n = 12,331
3-y follow-up

Villalpando et al., 2015 (44)
Double-blind controlled trial:
school provided 2 × 200 mL
milk/d for 4 mo

TRIALS (2 studies)
Hendrie and Golley, 2011 (43)
Randomized controlled trial:
12-wk intervention to switch
to reduced-fat dairy or not;
follow-up at 24 wk

Study and reference

r

r

r
Excess fat
mass at 13 y
(DXA, top 20%
of sample)
Overweight at
10 y and 13 y3
BMI

Self-report
BMI

Weight
BMI
WC

r
r
r

r

BMI
BMI-z
WC

r
r
r

Outcome measures

3-d food record at baseline and
3-y follow-up to assess
intake of whole or
reduced-fat milk, cheese or
yogurt.
Reduced-fat dairy products
included those made with
semiskimmed (1.7%) or
skimmed milk and any
reduced-fat cheese or
yogurt. Dairy products made
with whole milk were
categorized as full fat.

1) Whole, 2%, 1%, or skim milk
intake
2) Dairy fat (both total value
and energy adjusted) from
milk, butter, and cheese as
both whole foods and as
ingredients.

132-item 1-y FFQ for youth,
completed at baseline and
annually to assess:

Whole (>2% for milk and
yogurt, ≥25% for cheese);
hand reduced-fat (≤2% for
milk and yogurt, <25%
cheese) dairy at baseline,
12 wk, and 24 wk from
3 × 24-h diet recalls.
Milk provided was either 3%,
2%, or 0.5% fat. 130/462
subjects completed diet
interview at 2 mo and 3 mo
after baseline.

Exposure variables

TABLE 1 Summary of research examining dairy intake by fat content with obesity measures in children1

Sex, maternal education,
maternal weight status;
baseline age, height, BMI,
intake of cereal, total fat,
protein, ﬁber, 100% fruit
juice, fruit and vegetables,
sugar sweetened beverages;
follow-up dairy intake,
energy intake; physical
activity, pubertal stage,
dieting and; dietary
misreporting.

Same-year physical activity and
inactivity, race and ethnicity,
same-year height growth,
age, prior-year BMI-z, Tanner
stage, menstrual history.
Models run separately for boys
and girls.

Adjusting for clustering of
children in schools.

Clustering of children within
families, age, sex, baseline
BMI z-score, family income,
parental education, parental
BMI, baseline energy.

Confounders considered

Downloaded from https://academic.oup.com/advances/article-abstract/doi/10.1093/advances/nmaa011/5760740 by guest on 23 April 2020

Whole- or reduced-fat dairy in children 5

(Continued)

Whole-fat dairy consumption
at 10 y was associated with
less excess fat mass at 13 y
(all models P ≤ 0.06), and
smaller 3-y change in BMI∗∗ ,
reduced-fat not signiﬁcantly
associated with adiposity.
No signiﬁcant associations
with dairy type and BMI at
follow-up.

1) Consumption of 1% milk
(boys) and skim milk (girls)
was signiﬁcantly associated
with subsequent BMI gain.
Whole-milk intake was not
associated with BMI change
2) Dairy fat intake was not
signiﬁcantly associated with
BMI change.

Changing from whole-fat milk
consumption to reduced-fat
or skim did not result in
changes to measures of
adiposity.

Changing from whole- to
reduced-fat dairy
consumption did not result
in changes to measures of
obesity.

Results and conclusions2
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Subjects

US children 4 y at baseline (SD
not given),
∼49% F
n = 700

Canadian monozygotic twin
pairs
9 ± 0.6 y at baseline, 56% F
n = 210 (105 pairs at 14 y)

US children
∼2 y at baseline,
(% F not speciﬁed)
n = 852

UK children
11 ± 0.2 y at baseline,
55% F
n = 2245 at 1-y follow-up
n = 2270 at 3-y follow-up

Study and reference

ECLS-B
DeBoer et al., 2015 (47)
1-y follow-up

QNTS
Dubois et al., 2016 (48)
5-y follow-up

Project Viva cohort study
Huh et al., 2010 (49)
1-y follow-up

ALSPAC
Noel et al., 2011 (50)
3-y follow-up

TABLE 1 (Continued)

r

r
r

r

r
r

Fat mass from
DXA at 11 y
and 13 y

BMI-z
Overweight
deﬁned as
BMI for age
and
sex ≥85th
percentile

Change in
BMI4

BMI-z
Weight-forheight

Outcome measures

Whole- or reduced-fat milk
(including skim, not further
deﬁned) svs/d (1 sv =
∼250 mL milk) and g/d from
3-d food record, at baseline
and follow-up.
Skim not examined separately
due to small sample size.

Whole, 2%, 1%, or skim milk
svs/d at baseline from FFQ.

Whole-fat and reduced-fat milk
(not further deﬁned, as kcal
and % of energy) at baseline
and follow-up, from
24-h-recall interviews.

Parents asked frequency and
type of milk consumption
(whole milk, 2%, 1%, skim)
over past week at baseline.

Exposure variables

Three models used, including
age, sex, ethnicity, energy
intake, nondairy beverage
intake, TV viewing, maternal
BMI and education, paternal
BMI, BMI z-score at baseline
(also considered ﬁber, other
caregiver time, sleep, height,
physical activity).
Model 3 restricted to 656
children with BMI within 5th
to 85th percentile at
baseline.
Age, sex, height,4 baseline BMI,
maternal education,
maternal BMI, physical
activity, pubertal stage, and
intakes of total fat, breakfast
cereal, 100% fruit juice,
sugar-sweetened beverages,
calcium intake, total energy
%, + restricted for plausible
energy intake.

Age of twin at assessment
2 analyses:
1) intrapair variability
2) BMI-discordant and
BMI-concordant5 intrapair
diﬀerences.

Sex, race/ethnicity, SES.

Confounders considered
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(Continued)

Neither whole-fat nor
reduced-fat milk was
associated with % fat mass.

Higher fat content of milk
consumed at baseline
associated with lower rates
of being overweight 1 y
later.∗∗
1) Change in reduced-fat milk
intake was positively
associated with BMI change
from 9 to 14 y in kcal∗ and %
energy∗∗ for girls; no
signiﬁcant associations for
boys or for whole-fat milk
2) For girls: lower intake of
whole-fat milk (% energy)
and higher intakes of
reduced-fat milk observed at
baseline in the heavier of the
discordant twin pairs.∗
For boys: higher intake of both
types of milk at baseline by
the heavier twin.
Higher intake of whole-fat milk
at baseline, but not
reduced-fat milk, was
associated with lower BMI
z-score 1 y later∗ (but not
signiﬁcant when restricted
to only those who were
normal weight at baseline).
No signiﬁcant associations
observed with milk type at
baseline and overweight 1 y
later.

Results and conclusions2

US children
∼2 y at baseline,
49% F
n = 5150

US girls
10 ± 0.9 y at baseline (8–12 y),
100% F
n = 178

MIT Growth and Development
Study
Phillips et al., 2003 (21)
∼7-y follow-up

ECLS-B
Scharf et al., 2013 (52)
2-y follow-up

Australian adolescents
14 ± 0.2 y at baseline,
54% F
n = 860

Subjects

Raine Study
O’Sullivan et al., 2016 (51)
3-y follow-up

Study and reference

TABLE 1 (Continued)

r
r

r
r

r

BMI-z
Weight
status6

BMI z-score
% fat mass via
BIA using
electrodes

Waist-toheight
ratio

Outcome measures

Parents asked the type of milk
consumption in the past
week at 2 y, and frequency
and type at 4 y, in terms of
reduced-fat (<2%) or
whole-fat (≥2% fat).

Whole-fat and reduced-fat
dairy (given as svs/d, where
1 sv = 40 g cheese, 250 mL
milk, 200 g yogurt) as
assessed by 212-item
semiquantitative FFQ at
baseline and follow-up.
Reduced-fat classiﬁcations:
milk <3%, cheese <16%,
butter <50%, ice cream
<7%, yogurt <3%, dairy
dessert/custard <3%, cream
<30%.
Low-fat (deﬁned as skim milk,
yogurt, cottage cheese, ice
milk/sherbert) and full-fat
(deﬁned as whole milk,
cream, ice cream, sundaes,
cheese, cream cheese, and
milkshakes) dairy in svs/d
and % energy. Cheese from
pizza not included.
From 116-item 1-y
semiquantitative FFQ at
baseline and follow-up.

Exposure variables

For boys, increased
consumption of whole-fat
dairy associated with lower
waist-to-height ratio in
model adjusting for age,
misreporting status, and
energy intake∗ ;
nonsigniﬁcant associations
after adjustment for other
factors, or in girls.

Whole-fat (svs/d) and
reduced-fat dairy (svs/d)
considered together as
separate variables in models.
Age, energy intake, dietary
misreporting status, aerobic
ﬁtness, maternal age, ever
breastfed (yes/no), dietary
patterns. Models separated
by gender. Family factors,
income, medical history also
investigated as potential
confounding factors.
BMI z-score: chronological age,
fruit and vegetable
consumption,
sugar-sweetened beverage
intake, energy intake,
calories from protein, and
parental overweight
% fat mass: age relative to
menarche, physical activity,
energy intake, calories from
protein, parental
overweight.
Additional covariates
considered (for both
models): physical activity
and inactivity, ethnicity,
intake of fruit and
vegetables,
sugar-sweetened beverages,
snack foods, protein,
carbohydrate, and fat.
Sex, ethnicity, SES, juice and
sugar-sweetened beverages
intake, number of glasses of
milk daily, maternal BMI,
baseline BMI z-score (only for
odds of overweight or obese
over time).

(Continued)

Reduced-fat milk drinkers who
were not overweight or
obese at 2 y were more likely
to be overweight or obese
at 4 y when compared with
whole-fat milk drinkers.∗
No signiﬁcant associations
between milk type and
change in BMI-z.

Neither consumption of full-fat
nor low-fat dairy over time
was associated with
measures of obesity.

Results and conclusions2

Confounders considered
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Dutch teenagers
∼13 y at baseline,
53% F
n = ≥3747

Subjects

Mexican-American children in
the USA
9 ± 1 y (8–10 y), 53% F
n = 319

US children
∼3 y,
51% F
n = 145

Canadian children and
adolescents
2–18 y,
(% F not stated)
n = 10,038

Beck et al., 2014 (55)

Beck et al., 2017 (56)

CCHS
Danyliw et al., 2012 (57)

OBSERVATIONAL: CROSS-SECTIONAL (15 studies)
BRAVO Project and Gabbiano
Italian children
Study
8 ± 2 y (3–11 y), 50% F
Barba et al., 2005 (54)
n = 884

AGAHLS
te Velde et al., 2011 (53)
23-y follow-up at these time
points: 14, 15, 16, 21, 27, 32,
and 36 y

Study and reference

TABLE 1 (Continued)

r

r

r

r
r
r

r

r

r

r

At 36 y:

BMI
category11

Weight
category10

Obesity9

Overweight
status8
BMI-z
Weight
Height

Overweight
(BMI
≥25 kg/m2 )
Waist
circumference
Above or
below
median fat
mass from
DXA

Outcome measures

Beverage clusters from
1 × 24-h recall. Groups
based on dominant
beverage: mostly fruit drinks,
soft drinks, 100% juice, milk,
whole-fat milk, or
low-volume and varied
beverages.

Milk fat intake in grams from
whole, 2%, 1%, and skim
intakes, from 1 × 24-h recall.
Flavoured milk not included.

Usual consumption of whole,
2%, 1%, or skimmed milk
from diet interview.

Frequency of whole-fat milk
intake (deﬁned as not
skimmed or partially
skimmed milk) from 1-y FFQ.

Reduced-fat (≤2%) or
whole-fat dairy (>2%) from
dietitian-administered diet
history interview for
preceding 4 wk, assessed at
14, 15, 16, 21, 27, 32, and
36 y.

Exposure variables

Age, sex, birth weight, parental
overweight, physical activity,
parental education, intake of
dairy foods, ﬁsh, cereals,
meat, fruit, vegetables,
sugar-sweetened beverages,
snacks.
Fast-food consumption, screen
time, physical activity,
maternal country of origin,
maternal Spanish language
use (as a measure of
acculturation), maternal
education, household
income, maternal
occupational status.
Intakes of total fat, energy, total
milk; maternal education,
maternal y in USA, maternal
language, maternal BMI,
maternal marital status.
Age, sex (for 2–5 y only), energy
intake, ethnicity, sedentary
activity, and
sociodemographic
characteristics.

Sex, energy intake, physical
activity, smoking status.

Confounders considered
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(Continued)

Being in the whole-fat milk
cluster was nonsigniﬁcantly
associated with odds of
being overweight or obese.

Unadjusted, whole-milk
consumption was
associated with lower odds
of obesity, 2% milk
associated with higher odds.
Nonsigniﬁcant in adjusted
models (trend for whole milk
intake associated with lower
risk of obesity, P = 0.07).
Milk fat consumption was
associated with lower odds
of severe obesity.∗

Whole-fat milk intake
frequency associated with
lower BMI z-score∗∗ and
lower chance of being
overweight.∗∗

No signiﬁcant diﬀerences with
measures of adiposity in
whole- or reduced-fat dairy
intake at any adolescent
time points.

Results and conclusions2

Iranian school children
12 ± 3 y (6–18y),
49% F
n = 13,486

Argentinian children and
adolescents
10 ± 2 y (5–14 y), 52% F
n = 365

US children
2–5 y, 53% F
n = 541
6–11 y, 48% F
n = 793

Hirschler et al., 2009 (60)

NHANES
LaRowe et al., 2007 (61)

US children
∼4 y,
49% F
n = 8950
Swedish children
∼8 y,
∼46% F12
n = 109

Subjects

CASPIAN-IV
Fallah et al., 2016 (59)

Eriksson and Strandvik, 2010
(58)

ECLS-B
DeBoer et al., 2015 (47)

Study and reference

TABLE 1 (Continued)

WC
BMI

BMI

r
r

r

Overweight
and obese
categories
based on
BMI13

BMI

r

r

BMI-z
Weight-z
Height-z

r
r
r

Outcome measures

Pediatrician interview with
mother to determine 3
categories of whole-fat milk
consumption (not further
deﬁned) according to daily
recommendations (≤1, 2–3,
or ≥4 svs/d).15
Whole-fat milk (≥2%) beverage
diet pattern, from cluster
analysis of 1 × 24-h recall,
<6 y proxy interview of
parent.
Four other beverage diet
patterns identiﬁed: mix/light
drinker, water, sweetened
drinks, and soda.

Parents asked frequency and
type of milk consumption
(whole milk, 2%, 1%, skim)
over past week.
Milk intake (deﬁned as whole
3% fat, medium 1.5%, low
0.5%) from 69-item FFQ past
1 y, completed by parent
with child.
Modiﬁed questionnaire14 used
to assess whole-fat or
low-fat milk type (not further
deﬁned) usually consumed.

Exposure variables

Age, sex, ethnicity, household
income, birth weight,
physical activity, Healthy
Eating Index score.

None.

Sex, age, physical activity,
screen time, birth weight,
milk type in infancy, and
frequency of other food
groups consumed; plus
frequency of milk
consumption.

None speciﬁed for the
whole-fat milk analysis.

Sex, ethnicity, SES.

Confounders considered
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(Continued)

2–5 y: BMI not signiﬁcantly
diﬀerent across diet patterns.
6–11 y: whole-fat milk pattern
associated with lower BMI
than water, sweetened
drinks, and soda patterns.∗
No signiﬁcant associations
with mix/light drinker
pattern, which had higher
reduced-fat milk intake.

Higher fat content of milk
associated with lower BMI,
weight, and height
z-scores.∗∗
Whole-fat milk consumption
associated with lower BMI.∗∗
No signiﬁcant associations
between BMI and
reduced-fat milk intake.
Usual consumption of
whole-fat milk was
associated with lower odds
of overweight and obesity
compared with those who
usually consumed
reduced-fat milk∗∗ across
unadjusted and adjusted
models (in both M and F,
stronger association in F).
Additional protective eﬀect
of nonpasteurized whole-fat
milk.
Higher intake of whole-fat
dairy associated with lower
waist circumference.∗
No signiﬁcant associations
with BMI.

Results and conclusions2

O’Sullivan et al.

NZ children
2 to <5 y, 49% F
n = 1329

US children
∼15 ± 1.7 y, ∼57% F
n = 536

UK adolescents
13.8 ± 0.2 y,
55% F
n = 2270

US children
3 y (2–5 y),
50% F
n = 1160

TFADS
Nezami et al., 2016 (63)

ALSPAC
Noel et al., 2011 (50)

NHANES
O’Connor et al., 2006 (64)

Subjects

Te Ra Whakaora (Sunshine and
Health)
Mazahery et al., 2018 (62)

Study and reference

TABLE 1 (Continued)

r

r

r

r

r
r
r

r

Overweight
or obese from
BMI20

% fat mass
from DXA

BMI-z
Weight-z
Weight-toheight
ratio
BMI
categories19
% fat mass
from BIA

Overweight
or obese from
BMI16,17

Outcome measures

Whole, 2%, 1%, and skim milk
oz/d, from 1 × 24-h recall.

Whole or reduced-fat milk
(including skim, not further
deﬁned) svs/d (1 sv
≈250 mL milk) and g/d from
3-d food record, at baseline
and follow-up.
Skim not examined separately
due to small sample size.

Questionnaire asking parents if
the child usually consumed
cow milk and to specify the
usual type (grouped into
standard/full-fat or
low/reduced-fat, not further
deﬁned).18
Whole, reduced-fat, and
skim/nonfat milk (not further
deﬁned), from 151-item SQ
FFQ.

Exposure variables

Age, sex, height, maternal
education, maternal BMI,
physical activity, pubertal
stage, and intakes of total fat,
breakfast cereal, 100% fruit
juice, sugar-sweetened
beverages, calcium intake,
total energy, plausible
energy intakes.
Age, sex, ethnicity, household
income, energy intake,
physical activity.

Age, site, ethnicity, energy
intake, maternal education,
soda intake, physical activity,
milk substitute intake.
Separate models by gender.

Age, sex, ethnicity, household
size, education center
attendance, parental
education, SES, residential
region, milk allergy.

Confounders considered
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(Continued)

No signiﬁcant associations
were observed between
types of milk and measures
of obesity.

For all models, whole-fat milk
consumption was associated
with lower % fat mass.∗∗
Reduced-fat milk
consumption was
nonsigniﬁcantly associated
with obesity measures.

Milk type was nonsigniﬁcantly
associated with obesity
measures.

Children in the overweight
category were more likely to
be reduced-fat milk
drinkers.∗
Nonsigniﬁcant for obese
category.

Results and conclusions2

Greek school children
7–15 y,
47% F
n = 607
US children
2 y and 4 y
(% F not speciﬁed)
n = 7450 at 2 y
n = 8300 at 4 y

Subjects

r
r

r

BMI-z
Overweight
or obese22

Overweight
or obese from
BMI21

Outcome measures

Whole-fat (≥2%) and
reduced-fat (1%/skim) milk,
from parental questions on
frequency and type of milk
at 4 y and type at 2 y.

Whole, 2%, 1%, and skim milk
(mL/d and kcal) from
3 × 24-h recall.

Exposure variables

Sex, ethnicity, SES, maternal
BMI, juice, sugar-sweetened
beverages intake, glasses
milk/d, maternal BMI.

None.

Confounders considered

No signiﬁcant associations
were observed between
types of milk adiposity
categories.
Odds of being classiﬁed as
overweight or obese
increased among drinkers of
reduced-fat compared with
whole-fat across all models∗
except unadjusted at 4 y,
which was nonsigniﬁcant.

Results and conclusions2

AGAHLS, Amsterdam Growth and Health Longitudinal Study; ALSPAC, Avon Longitudinal Study of Parents and Children; BIA, bioelectrical impedance analysis; BMI-z, BMI z-score; CASPIAN, Childhood and Adolescence Surveillance and Prevention
of Adult Noncommunicable diseases; CCHS, Canadian Community Health Survey; ECLS-B, Early Childhood Longitudinal Study, Birth Cohort; NZ, New Zealand; QNTS, Quebec Newborn Twin Study; SES, socioeconomic status; sv, serving; TFADS,
Teen Food and Development Study; WC, waist circumference.
2
Signiﬁcance level: ∗∗ P < 0.01; ∗ P < 0.05.
3
As deﬁned by BMI age- and gender-speciﬁc categories (to match adult 25- and 30-kg/m2 categories).
4
Height and weight were self-reported at follow-ups (researcher measured at baseline).
5
BMI-discordant twin pairs were deﬁned as twin pairs diﬀering by ≥2 BMI units, concordant diﬀered by <2 BMI units.
6
Categories were normal weight (<85th percentile), overweight (>85th to 95th percentiles), and obese (>95th percentile).
7
Numbers varied per follow-up: started with n = 634, ﬁnished with n = 374 with adult outcome measures. Exact numbers used at each follow-up not reported.
8
Overweight deﬁned according to the criteria based on age- and sex-speciﬁc cutoﬀ values obtained from centile curves leading to a BMI of 25 kg/m2 at 18 y.
9
BMI was converted to a dichotomous variable of obese (BMI ≥95th percentile) or not obese.
10
Overweight, obesity, and severe obesity = BMI ≥85th percentile; obese and severe obesity = BMI ≥95th percentile; severe obesity = BMI ≥99th percentile.
11
BMI-for-age categories using CDC criteria: normal as 5th to 85th percentiles, overweight as 85th to 95th percentiles, and obese as ≥95th percentile.
12
Approximate percentage based on larger study n = 112.
13
BMI between 85th and 95th percentiles was considered as overweight, and levels ≥95th percentile obese (age and gender speciﬁc). These were added together to make 1 category of overweight/obese (66).
14
WHO Global school-based student health survey, ﬁlled out by students under the supervision of staﬀ and the presence of ≥1 parent.
15
Recommended servings of milk per day were 2 cups for children aged 4–8 y, and 3 cups for children aged 9–18 y (where 1 cup was assumed to be a US cup of 237 mL) (67).
16
Scales used were noncalibrated.
17
Age- and gender-speciﬁc normal, overweight, or obese BMI cutoﬀs (68).
18
Children who usually consumed both whole- and reduced-fat milk were classiﬁed into the whole-fat group.
19
Based on WHO standards (69, 70).
20
BMI percentiles used: normal weight <85%, overweight 85% to <95, obese ≥95%.
21
Age- and gender-speciﬁc normal, overweight, or obese BMI cutoﬀs (68).
22
BMI converted to age- and gender-speciﬁc percentiles and z-scores using the 2000 CDC US growth charts. Weight categories were normal weight <85%, overweight >85 to 95%, and obese >95%.

1

ECLS-B
Scharf et al., 2013 (52)

Papandreou et al., 2013 (65)

Study and reference

TABLE 1 (Continued)
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Whole-fat and reduced-fat dairy and adiposity in
children
Of the studies investigating both whole- and reduced-fat
dairy, none reported a positive association between adiposity
measures and whole-fat dairy consumption. Some reported
inverse associations with consumption of whole-fat dairy, but
not reduced-fat dairy (46, 47, 49, 50, 58, 59). Others reported
positive associations with adiposity measures for intake of
reduced-fat, but not whole-fat dairy consumption (45, 52,
59, 62).
Taking into consideration study quality, the strongest
evidence we found was a 12-wk randomized controlled trial
of 145 children from 93 Australian families who were wholefat dairy consumers, aged between 4 and 13 y (43). The
intervention consisted of advice to change dairy products to
reduced-fat (≤2% fat for milk and yogurt, ≤25% for cheese),
whereas the control group consisted of parental advice to
replace screen activity with other sedentary activity (e.g.,
drawing, reading, or games). Families were not blinded to
the intervention. Dietary intake was assessed by three 24-h
recalls, and completed at baseline, 12 wk, and 24 wk
(although the intervention ceased at 12 wk). BMI, BMI zscore, and waist circumference were the adiposity measures
investigated in multilevel analyses, which were adjusted for a
range of child- and family-level covariates (Table 1). Wholefat dairy consumption decreased from 88% to 14% of total
dairy consumed at week 12 in the intervention group, and
consumption of reduced- and low-fat products increased
by 85%. As a result, total and saturated fat intakes from
dairy foods were significantly lower in the intervention
group. No group differences were observed in total dairy
or energy intake. This study also used serum pentadecanoic
acid (15:0) concentrations, presented as the percentage of
total fatty acids, as a biomarker of dairy fat intake. The
intervention group had significantly lower pentadecanoic
acid concentrations than the comparison group at week 12,
12

O’Sullivan et al.

suggesting a lower intake of dairy fat. This difference was
not significant at week 24. Despite the successful change
in the type of dairy intake, no significant differences were
seen in any measures of adiposity between the intervention
and control groups after 12 wk of intervention (mean
difference BMI = −0.16/m2 , P = 0.18; BMI z-score = −0.08,
P = 0.19; waist circumference = −0.39 cm, P = 0.38) or
at the subsequent 24-wk follow-up (mean difference BMI =
−0.15/m2 , P = 0.63; BMI z-score = −0.07, P = 0.51; waist
circumference = 0.30 cm, P = 0.69).
The only other trial that investigated adiposity outcomes
was a double-blind (non-randomized) controlled trial of
schoolchildren aged 6–16 y, who were usual consumers of
whole-fat milk, staying in 13 Indigenous boarding schools
in Mexico (44). School milk was provided to each child
on weekdays (2 × 200 mL/d), with schools receiving either
1) reduced-fat (2% fat) milk, or 2) skim (0.5% fat) milk,
or 3) staying on their usual whole-fat (3% fat) milk, for
a 4-mo period. The whole-fat and reduced-fat milks were
both provided as powders (and made up at the school
site), whereas the skim milk was provided fresh. To provide
data on energy and macronutrient consumption, along with
milk intake, 130 of 462 participating children (10 from
each school) completed a diet interview with plate and
glass weighing at 2 and 3 mo after baseline. Energy and
carbohydrate intake between the 3 groups did not change
differentially, although it was noted that tortilla consumption
increased in the 2% (45 g/d) and skim-milk (100 g/d,
P < 0.05) groups, compared with the whole-fat group.
Analyses were adjusted for clustering of schools but not for
any other factors. No significant differences between wholeand reduced-fat or skim groups for any measure of adiposity
were observed after 4 mo (BMI P = 0.23 and P = 0.39,
respectively; waist circumference P = 0.13 and P = 0.22,
respectively).
In the prospective studies identified, some reported
inverse associations between measures of adiposity and
consumption of whole-fat dairy while also reporting either
no significant associations (46, 49) or a positive relation
(45, 47, 52) between reduced-fat dairy consumption and
adiposity. Follow-up time for the prospective studies was
typically ∼1–3 y, with 1 study having a 7-y follow-up (21)
and 1 following adolescents through to adulthood (53). Both
these studies with longer time frames found no significant
associations between whole- or reduced-fat dairy intake and
adiposity measures.
The prospective study to adulthood by te Velde et al.
(53) was the Amsterdam Growth and Health Longitudinal
Study, conducted in the Netherlands. Thirteen-year-olds
(n = 634) were followed up at regular intervals to the age
of 36 y (n = 374), for measures of adiposity including
BMI (overweight defined as BMI ≥25 kg/m2 ), waist circumference, and fat mass as determined by DXA. Intake
of dairy was grouped as either low-fat or high-fat from
dietitian-administered diet histories for the preceding 4-wk
period. The dietary assessment considered a wide range of
dairy products beyond milk, including fromage frais, butter,
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reduced-fat dairy intakes, and a further 5 reported on dairy
fat, or whole-fat dairy intake, or whole-fat dairy clusters (i.e.,
a dietary pattern rich in whole-fat dairy) only (Table 1). For
research examining cardiometabolic risk factors, 6 journal
articles investigated whole- and reduced-fat dairy intakes,
1 investigated whole-milk consumption only, 1 investigated
milk type and amount, and 2 investigated biomarkers of dairy
fat intake (Table 2).
The ages of the children studied ranged from 2 y (49, 52,
57, 61, 62, 71) through to mid- and late adolescence (21,
51, 57, 59, 63, 72). One study followed adolescents through
to adulthood (53). The majority of studies were conducted
in the United States, with other countries contributing ≤3
studies (Argentina, Australia, Canada, Greece, Iran, Italy,
Mexico, the Netherlands, New Zealand, Sweden, and the
United Kingdom).
Sample sizes ranged from 93 (73) to 13,486 (59). Two studies were intervention trials, of which only 1 was a randomized
controlled trial (43). The remainder of the studies were either
prospective or cross-sectional observational studies.

Mexican children from 13
boarding schools
11 ± 3 y (6–16 y),
(% F not speciﬁed)
n = 462
Usual consumers of whole-fat
dairy at baseline

Australian children 8.6 ± 3.0 y
(4–13 y), 40% F
n = 145
Consuming ≥2 svs/d of
whole-fat dairy at baseline

Subjects

AGAHLS
te Velde et al., 2011 (53)
23-y follow-up at
these time points: 14,
15, 16, 21, 27, 32, and
36 y

Dutch teenagers
∼13 y at baseline,
53% F
n = ≥3746

OBSERVATIONAL: PROSPECTIVE (3 studies)
Raine Study
Australian adolescents
O’Sullivan et al., 2016
14 ± 0.2 y at baseline,
(51)
54% F
3-y follow-up
n = 860

TRIALS (2 studies)
Hendrie and Golley, 2011
(43)
Randomized controlled
trial: 12-wk
intervention to switch
to reduced-fat dairy or
not; follow-up at
24 wk
Villalpando et al., 2015
(44)
Double-blind controlled
trial
School provided 2 ×
200 mL milk/d for
4 mo

Study and reference

•
•

HDL-C
BP

At 36 y, above or
below median for
nonfasting:

r
r
r
r
r
r

MetS4
Low or high
metabolic
risk5
TC:HDL-C
HDL-C
LDL-C
BP
HOMA-IR
CRP

TG
TC
HDL-C
LDL-C
VLDL-C
TC:HDL
ApoB, apoA-1
Lp(a)
ApoB:apoA-1

r
r
r
r
r
r
r
r
r
r
r

TC
HDL-C
LDL-C
TG

r
r
r
r

Outcomes2

Reduced-fat (≤2%) or
whole-fat dairy (>2%) from
dietitian diet history
interview for preceeding
4 weeks.

Whole-fat and reduced-fat
dairy (given as svs/d) as
assessed by 212-item
semiquantitative FFQ at
baseline and follow-up.
Reduced-fat classiﬁcations:
milk <3%, cheese <16%,
butter <50%, ice
cream <7%, yogurt <3%,
dairy dessert/custard <3%,
cream <30%.

Milk provided was either 3%,
2%, or 0.5% fat.130/462
subjects completed diet
interview at 2 mo and 3 mo
after baseline.

Whole-fat (>2% for milk and
yogurt, ≥25% for cheese)
and reduced-fat (≤2% for
milk and yogurt,
<25% cheese) dairy at
baseline, 12 wk, and 24 wk
from 3 × 24-h diet recalls.

Exposure variables

TABLE 2 Summary of research examining dairy intake by fat content with cardiometabolic factors in children1

Age, energy intake, dietary
misreporting status, aerobic
ﬁtness, maternal age,
breastfeeding, dietary
patterns, and BMI where
appropriate; family factors,
income, medical history also
investigated.
Whole-fat (svs/d) and
reduced-fat dairy (svs/d)
considered together in
models.
Separate analysis by sex.
Sex, energy intake, physical
activity, smoking status.

Clustering within schools.
Age, sex, BMI.

Clustering of children within
families, age, sex, baseline
BMI-z, family income,
parental education, parental
BMI, baseline energy.

Confounders considered
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(Continued)

Adults with TG above the
median had higher intakes
of reduced-fat dairy at 16 y
compared with those below
the median.∗
Adults with HbA1c above the
median had higher median
intakes of whole-fat dairy at
14 y, compared with

In boys: increases in wholeand reduced-fat dairy both
associated with reduction in
diastolic BP∗ ; reduced-fat
dairy intake also associated
with reduction in HDL-C∗
and increased TC:HDL-C∗
In girls: no signiﬁcant
associations.

Switching from whole-to skim
milk resulted in decreased
LDL-C∗ , TC∗∗ , apoB∗∗ , but
also decreased HDL-C.∗∗ No
change to total:HDL-C.
Switching from whole- to
reduced-fat milk decreased
LDL-C∗ , apoA-1∗ , apoB.∗∗ No
change in TC:HDL-C or
apoB:apoA-1.

Switching from whole- to
reduced-fat dairy did not
result in signiﬁcant changes
to TC, HDL-C, or TG at 12 wk.
Small reduction in LDL-C at
24 wk (12 wk
post-intervention).∗

Conclusions3

O’Sullivan et al.

Canadian children 4±2 y
(2–8 y),
47% F
n = 2890 at baseline.
Only 32% completed ≥2 visits
(<4% completed ≥4 visits)

Subjects

Iranian children
15 ± 3 y (10–19 y), 53% F
n = 785

Argentinian children and
adolescents 10 ± 2 y
(5–14 y), 52% F
n = 365

Swedish adolescents ∼15 y,
55% F
n = 93

TLGS
Ghotboddin
Mohammadi et al.,
2015 (72)

Hirschler et al., 2009 (60)

Samuelson et al., 2007
(73)

OBSERVATIONAL: CROSS-SECTIONAL (5 studies)
CASPIAN-IV
Iranian school children
Fallah et al., 2016 (59)
12 ± 3 y (6–18 y),
49% F
n = 13,486

TARGet Kids!8
Wong et al., 2019 (71)
Annual follow-up

Study and reference

TABLE 2 (Continued)

r

TG
TC
Insulin
ApoB (n = 50)
ApoA-1
(n = 49)
ApoB:apoA-1

BP
HDL-C
HOMA-IR
Insulin
TG

r
r
r
r
r

r
r
r
r
r

MetS 13

Elevated BP
based on
pediatric
cut-points11

Nonfasting
non-HDL-C9
“High-risk” cut
point of
3.75 mmol/L
also applied10

TG, HbA1c
Adapted MetS
status7

r

r

r

r

r
r

Outcomes2

Serum cholesterol ester fatty
acid composition (%) for
15:0 and trans-16:1n–7.
Proportion of dietary fatty
acids adjusted for energy
intake (from 7-d weighed
food records) for
trans-16:1n–7.

3 categories of whole-fat milk
consumption (≤1, 2–3,
or ≥4 svs/d),14 from
pediatrician interview with
mother.

Low- and high-fat dairy
(undeﬁned) from a 168-item
1-y semiquantitative FFQ.

Modiﬁed questionnaire12 used
to assess whole-fat or
low-fat milk type (not further
deﬁned) usually consumed.

1) Report type of milk typically
consumed by child: skim,
1%, 2%, or whole (3.25%);
2) Select how many cups the
child consumes in a typical
day

Questionnaire asked parents to

Exposure variables

BMI, physical activity, vegetable
and juice intake, separate by
gender.

Sex, age, physical activity,
screen time, BMI, birth
weight, milk type in infancy,
family history of
hypertension, and frequency
of other food groups
consumed; plus frequency
of milk consumption.
Age, sex, energy, BMI included
in models of total dairy but
no confounders speciﬁed for
reduced- or whole-fat dairy
analysis.
Only for HOMA-IR model:
physical activity, television
viewing, sugar-sweetened
beverage intake, parental
education, sex, age, HDL-C,
systolic BP.

Age, sex, BMI z-score, daily free
play, breastfeeding duration,
mother’s ethnicity, family
income, parental history of
CVD.
Further adjusted for typical
volume of milk consumed.

Confounders considered
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14
Systolic BP (inverse)∗∗
HDL nonsigniﬁcant
HOMA-IR (inverse)∗
Insulin (inverse)∗
TG nonsigniﬁcant

r
r
r
r

(Continued)

TC∗ (F and M)
ApoA-1∗∗ (F)
ApoB∗ (M)
ApoB:apoA-1∗ (M)

Serum 15:0% associated with
lower:

r
r
r
r
r

Whole-fat milk associated with
lower HOMA-IR in adjusted
models.∗ Unadjusted
associations across intake
groups:

Type of dairy products
consumed was not
associated with odds of
MetS.

Usual consumption of
whole-fat milk was not
associated with odds of
elevated BP in boys or girls.

Increase in milk fat percentage
was associated with a slight
increase in non-HDL-C in
unadjusted∗∗ and adjusted∗
analysis.
Milk fat was not associated
with increased odds of
having high non-HDL-C.

those below the median.∗ No
signiﬁcant associations with
other outcomes.

Conclusions3

US adolescents
∼15 y,
43% F
n = 305

Subjects

r

r
r

r
Serum
adiponectin
CRP
Cytokines (IL-6
and TNF-α)
Urinary F2-iso
and 15-keto

Outcomes2

Serum phospholipids 15:0
and17:0.
Also used 127-item FFQ to
adjust for other diet factors.

Exposure variables

Age, gender, ethnicity, Tanner
score, total energy intake,
physical activity; diet factors:
calcium, potassium,
phosphorus, vitamins A and
D, ω-3 fatty acids, protein,
total ﬂavonoids, and BMI if
appropriate.
Separate analysis by weight
status.

Confounders considered

TG∗ (F)
ApoB∗ (M)
ApoB:apoA-1∗ (M)

• TG∗ (F)
Serum 17:0 and 15:0 inversely
associated with
inﬂammation and oxidative
stress∗∗ in overweight
adolescents. IL-6 inversely
related to 17:0 and 15:0
independent of weight
status.∗∗
17:0 positively associated with
adiponectin in overweight
adolescents∗ but inversely
associated in normal-weight
adolescents.∗
No signiﬁcant results for
TNF-α.

Dietary % 16:1n–7 associated
with lower:

•
•
•

Serum % 16:1n–7 associated
with higher:

Conclusions3

AGAHLS, Amsterdam Growth and Health Longitudinal Study; BMI-z, BMI z-score; BP, blood pressure; CASPIAN, Childhood and Adolescence Surveillance and Prevention of Adult Noncommunicable diseases; CRP, C-reactive protein; CVD,
cardiovascular disease; F2-iso, F2-isoprostanes; HbA1c, glycated hemoglobin; HDL-C, HDL cholesterol; HT, hypertension; LDL-C, LDL cholesterol; Lp(a), lipoprotein(a); MetS, metabolic syndrome; sv, serving; TARGet Kids!, The Applied Research Group
for Kids; TC, total cholesterol; TG, triglyceride; TLGS, Tehran Lipid and Glucose Study; VLDL-C, VLDL cholesterol; WC, waist circumference; 15-keto, 15-keto-dihydro-PGF2alpha.
2
Fasting measures reported for blood results.
3
Signiﬁcance level: ∗∗ P < 0.01; ∗ P < 0.05.
4
As deﬁned by the International Diabetes Federation pediatric criteria (75).
5
Derived from the data using cluster analysis.
6
Numbers varied per follow-up: started with n = 634, ﬁnished with n = 374 with adult outcome measures. Exact numbers used at each follow-up not reported.
7
Metabolic syndrome was deﬁned as the presence of ≥2/5, as adapted from 3/5 according to the deﬁnition, of the following components: WC >94 cm in M or >80 cm in F; TG concentration >150 m/dL (1.69 mmol/L); serum HDL-C <40 mg/dL
(1.03 mmol/L) in M and <50 mg/dL (1.29 mmol/L) in F; systolic BP >130 mmHg and/or diastolic BP >85 mmHg; HbA1c >6.2% (76).
8
Although this study is reported as a longitudinal study, it was treated as cross-sectional for the purposes of this review because the relation between dairy fat intake and non-HDL-C was assessed cross-sectionally within the analyses (32% of
subjects provided data from 2 visits, <4% from ≥4 visits): “…generalized estimating equations with an exchangeable correlation structure, which takes into account potential correlation within subjects with repeated measures.”
9
Calculated by subtracting HDL-C from TC.
10
Cut points were based on the US National Heart, Lung, and Blood Institute Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents (77).
11
Elevated BP was categorized as pre-HT and HT according to the Fourth Report of the Working Group on Blood Pressure Control in Children (78). Pre-HT was considered as either BP equal to or greater than the age- and gender-speciﬁc 90th
percentile after adjusting for weight and height, or as BP ≥120/80 mmHg. When BP was equal to or greater than the age- and gender-speciﬁc 95th percentile value, it was considered as HT.
12
WHO Global school-based student health survey, ﬁlled out by students under the supervision of staﬀ and the presence of ≥1 parent.
13
MetS deﬁned as having ≥3 of the following components: fasting plasma glucose concentration ≥110 mg/dL; fasting serum TG ≥100 mg/dL; HDL-C <45 mg/dL for boys aged 15–19 y and <50 mg/dL for other people; WC >75th percentile for
the age and sex of Iranian population; systolic and diastolic BP >90th percentile for age, sex, and height based on the recommendations of the National Heart, Lung and Blood Institute.
14
Recommended serving of milk per day was 2 cups for children aged 4 to 8 y, and 3 cups for children aged 9 to 18 y (67).

1

Wang et al., 2011 (74)

Study and reference

TABLE 2 (Continued)
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scales, to investigate cross-sectional associations with obesity
measures in ethnically diverse US adolescents participating
in the Teen Food and Development Study. Intake of wholefat, reduced-fat, and nonfat milk was assessed using a
151-item semiquantitative FFQ. Other dairy including
cheese and sweetened dairy was also considered but was
not separated according to fat content. Models were run
separately by gender and adjusted for age, site (2 sites used),
ethnicity, energy intake, maternal education, soda intake,
physical activity, and milk substitute intake. Although total
dairy intake in boys was positively associated with waist-toheight ratio, fat-free mass, and fat mass, the fat content of
the milk consumed was not associated with any measures
investigated.
We cannot discount the potential for reverse causality,
particularly in the cross-sectional studies. Children who are
overweight or obese, or have a family history of obesity could
be more likely to be provided with reduced-fat dairy in an
effort to reduce caloric intake. In contrast, children who
are underweight could be more likely to be given wholefat dairy foods. In an effort to control for this potential
effect in prospective studies, many controlled for baseline
and/or familial adiposity measures (Table 1). Additionally,
2 studies limited their analysis to participants who were not
overweight at baseline (49, 52). As is the case for this literature
overall, studies that took baseline adiposity into account,
by adjusting for it or by conducting stratified analyses,
indicate that whole-fat dairy is either inversely or not
associated with adiposity measures independent of baseline
adiposity.
Most studies included in this review relied on BMI or BMI
z-scores as a proxy measure of adiposity, with only 5 using fat
mass based on either DXA (46, 50, 53) or BIA (21, 63). Results
for those studies using DXA were similar to the other studies
using BMI as an end point: either whole-fat but not reducedfat dairy was either inversely associated with percentage
fat mass longitudinally (46) or cross-sectionally (50); or
neither type showed significant associations longitudinally
(50, 53). Results for both studies using BIA showed no
significant associations between body fat mass and whole-fat
or reduced-fat dairy intake.
Overall, a review of the available evidence suggests that
consumption of whole-fat dairy products, or dairy fat intake,
is not associated with an increase in adiposity measures.
Conversely, some studies reported positive associations
with intake of reduced-fat dairy, and inverse associations
with whole-fat dairy intake. These findings suggest that
consumption of reduced-fat dairy over whole-fat dairy is
unlikely to prevent obesity or to reduce excess adiposity in
children.

Whole-fat and reduced-fat dairy and cardiometabolic
disease risk biomarkers in children
Ten studies were identified that investigated the relation
between dairy intake by fat content and ≥1 cardiometabolic
disease risk biomarker, with some studies applying metabolic
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cream cheese, yogurts, and milk-based desserts. This gave a
more accurate assessment of total dairy intake than a focus
on milk alone. Confounders considered were sex, energy
intake, physical activity, and smoking status. No significant
associations with measures of adiposity were observed
for low- or high-fat dairy intake at any adolescent time
points.
The Growing Up Today study was 1 of the largest study
cohorts we reviewed, with almost 12,000 participants aged
9–14 y at baseline followed for 3 y (45). This study, investigating the children of Nurses’ Health Study II participants,
reported no significant association between dairy fat intake
as measured by an annual 1-y FFQ and yearly change in
self-reported BMI. The authors also reported sex differences
in association with milk consumption—consumption of
1% milk in boys was significantly (P < 0.05) positively
associated with BMI gain over a year [BMI change per
8 oz (244 g) serving, β = 0.027; 95% CI: 0.002, 0.053],
whereas in girls a significant (P < 0.05) positive association
was found with skim milk (BMI change per serving, β =
0.021; 95% CI: 0.001, 0.040). Whole-fat and 2% milk were
not significantly associated with BMI gain in either boys
or girls.
Differing associations by sex were also noted in a
prospective study of genetically identical twin pairs with
shared environments (48). Variation in dietary intake at age
9 y between sets of twins was compared with subsequent
differences in BMI at age 14 y. Within girl twin sets,
those consuming more reduced-fat milk were more likely
to positively increase BMI over time (Spearman ρ = 0.32,
P < 0.05); however, no significant associations were observed
in boys (Spearman ρ = 0.09, P > 0.05), or for whole-fat milk
(for girls, Spearman ρ = −0.16, P > 0.05; for boys, Spearman
ρ = 0.17, P > 0.05) (48).
The remaining prospective studies showed no significant
associations of whole-fat dairy or reduced-fat dairy consumption with adiposity outcomes in any models (21, 50) or
in fully adjusted models (51).
Most cross-sectional studies examining both whole- and
reduced-fat dairy consumption in relation to adiposity
measures reported that consumption of dairy with higher
fat content was associated with lower risk of obesity (47,
50, 52, 55, 58, 62) (Table 1). The remaining cross-sectional
studies examining consumption of both whole- and reducedfat dairy products reported no significant associations with
measures of adiposity for either type (63–65).
The majority of the cross-sectional studies examining
dairy fat or whole-fat dairy intake (not in comparison with
reduced-fat dairy) showed an inverse association with ≥1
measure of obesity (54, 56, 60, 61), whereas another showed
that being in a diet cluster characterized by a high whole-fat
milk intake was not associated with obesity measures (57)
(Table 1).
The study by Nezami et al. (63) utilized the widest range
of adiposity measures, including BMI z-score, weight z-score,
waist-to-height ratio, BMI categories, and percentage fat and
fat-free mass from bioelectrical impedance analysis (BIA)

syndrome classifications or using clustering to group highrisk children together.

Blood pressure.
There were no randomized controlled trials identified in this
review that investigated effects of whole-fat dairy on blood
pressure. Among the 2 prospective studies, the Australian
Raine Study demonstrated that increases in both whole- and
reduced-fat dairy intake were similarly associated with a
reduction in diastolic blood pressure in boys from early to
late adolescence (mean reduction in diastolic blood pressure
of 0.47–0.66 mmHg, P < 0.05) (51), whereas the Amsterdam
Growth and Health Longitudinal Study found no significant
association in teenagers that were followed through to
adulthood (53).
One cross-sectional study of Iranian schoolchildren
focused only on blood pressure as an outcome, with a
very large sample size (n = 13,486) and comprehensive
statistical models (59). Consumption of whole-fat milk was
not associated with odds of elevated systolic or diastolic
blood pressure in boys or girls, based on pediatric cut-points.
Intake of dairy outside of milk was not considered. The
only other cross-sectional study investigating blood pressure
found that those children consuming ≥4 glasses of whole-fat
milk/d had significantly lower systolic blood pressure than
those consuming ≤1 glass/d (95.8 ± 12.3 compared with
90.2 ± 10.8 mm Hg, P < 0.05) although this analysis did not
include an adjustment for potential confounding factors (60).
Inflammation and oxidative stress.
We found 2 studies that investigated relations between
whole- and reduced-fat dairy intake and fasting plasma CRP,
1 of which was the only study to investigate cytokines and
adiponectin along with measures of oxidative stress. One
prospective study found no association between the intake
of whole- or reduced-fat dairy and fasting plasma CRP
concentrations (51). In the other study, a cross-sectional
investigation, higher concentrations of serum phospholipid
dairy fatty acids (17:0 and 15:0) were associated with lower
IL-6 among adolescents, in adjusted analyses with other
dietary confounders considered (P-trend across quintiles
<0.001) (74). Obesity appeared to modify the relations—
dairy fatty acids were inversely associated with CRP, and
positively associated with adiponectin (17:0) in overweight,
but not in normal-weight adolescents (P-trend <0.01). No
significant associations were observed for TNF-α.
Indices of glucose metabolism.
No data on effects of whole-fat dairy consumption on indices
of glucose metabolism were available from controlled trials.
Whole- or reduced-fat dairy in children 17
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Serum lipids and apolipoproteins.
Our review identified 1 randomized controlled trial that investigated these outcomes. Hendrie and Golley (43) showed
that changing from whole- to reduced-fat dairy products
for 12 wk did not result in a significant change to LDL
cholesterol, HDL cholesterol, TC, or triglycerides over this
period. Similarly, the other (nonrandomized) controlled
trial by Villalpando and colleagues (44) also reported no
change in TC:HDL cholesterol when children in Mexican
boarding schools were switched from whole-fat to reducedfat or skim milk, because both LDL cholesterol and HDL
cholesterol were reduced. Only 1 prospective observational
study reported TC:HDL cholesterol, finding a significant
positive relation with reduced-fat (but not whole-fat) dairy
intake over time in boys, but not girls [each additional serving
of reduced-fat dairy was associated with a 2% increase in the
total:HDL cholesterol ratio (95% CI: 1.002, 1.03)]. This could
have been due to a significant inverse association between
reduced-fat dairy intake and fasting plasma HDL cholesterol
(51).
Non-HDL cholesterol (as calculated by TC minus HDL
cholesterol) was found to be positively associated with
percentage of milk fat typically consumed in a large Canadian
study (each percentage increase in milk fat was associated
with a 0.024-mmol/L increase in non-HDL cholesterol;
P = 0.01) (71), although the relation with HDL cholesterol was not reported. For triglycerides, studies reported
an inverse association with whole-fat dairy (participants
with a triglyceride concentration below the median at age
36 y consumed significantly more whole-fat dairy at 16 y,
averaging ∼400 g/wk more, P = 0.030) (53), or no significant
association (60). The dairy fatty acid 16:1n–7 was positively
correlated with triglycerides when assessed in terms of serum
cholesterol ester fatty acid composition percentage (Pearson
r = 0.30, P < 0.05), but negatively associated when assessed as
percentage energy in the diet (Pearson r = −0.32, P < 0.05),
in Swedish adolescent girls (73). The same study also showed
dairy biomarker serum 15:0 was associated with lower TC
in boys and girls (Pearson r = −0.34 and −0.32, respectively,
P < 0.05). Other studies did not show significant associations
with TC or individual lipid measures.
Two studies investigated apoA-1 and apoB. The Mexican
boarding school controlled trial by Villalpando et al. (44)
demonstrated that both apoA-1 and apoB decreased significantly in children who switched from whole- to reducedfat milk, with no significant change to the ratio (change
coefficient = −0.02, P = 0.15). Conversely, children who
switched to skim (defatted milk) showed significantly lower
apoB but not apoA-1, resulting in a significant decrease
in the apoB:apoA-1 ratio (change coefficient = −0.05,
P = 0.001). The potential complexities of the relation
between lipoproteins and dairy intake were highlighted by
the only other study that included apoA-1 and apoB as end
points, a cross-sectional analysis of Swedish adolescents by

Samuelson and colleagues (73). Serum cholesterol ester fatty
acid composition (percentage) for 1 dairy fat–related fatty
acid (pentadecanoic acid, 15:0) was significantly inversely
associated with the apoB:apoA-1 ratio in boys (correlation
coefficient = −0.50, P < 0.05) but not girls (data not shown).
However, another serum fatty acid linked to dairy fat intake
(trans-palmitoleic acid, trans-16:1n–7) was associated with a
significant positive association with the apoB:apoA-1 ratio in
boys (correlation coefficient = 0.45, P < 0.05).

Discussion
In children, is consumption of whole-fat dairy products
or dairy fat associated with higher measures of
adiposity? Do associations diﬀer for reduced-fat dairy
intake?
Despite the wide range of methods employed over a diverse
range of populations in the studies investigated, results were
unanimous in showing that whole-fat dairy products were
not associated with increased risk of weight gain or measures
of adiposity. On the contrary, some observational studies
identified a significant inverse relation that was not similarly
seen for reduced-fat dairy intake (45–50, 52, 54, 58, 62). Our
results agree with a previous review of dairy and obesity
in children (19), and with a meta-analysis of randomized
controlled studies with healthy adults (79), which found
similar associations for both whole- and reduced-fat dairy.
Consumption of whole-fat dairy products rather than
reduced-fat varieties could result in increased feelings of
satiety. In a randomized crossover trial, 48 Iranian children
consumed a breakfast with either skim milk or whole-fat
milk for 2 d (80). Children reported a higher satiety score
4 h after drinking whole-fat milk with breakfast compared
with skim milk. Young children are considered to be naturally
good at regulating their own appetite (81), and our results
suggest that including whole-fat dairy as part of the diet does
18
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not promote overconsumption of energy or weight gain. In
both the 2 controlled trials included in this review, overall
dietary energy intake remained similar in children changing
from whole-fat to reduced-fat dairy (43, 44). If children
decrease dairy fat in their diet, the source of the subsequent
compensatory calories could determine whether there is any
overall net effect on body weight. This could potentially
explain the variation in some studies finding an increased
risk of obesity for reduced-fat dairy products, compared with
whole-fat dairy.
In children, is consumption of whole-fat dairy products
or dairy fat associated with increased cardiometabolic
risk? Do associations diﬀer for reduced-fat dairy intake?
The research was less conclusive in the area of cardiometabolic risk biomarkers. Although almost all evidence
from the observational studies suggested that consumption
of whole-fat dairy was not associated with increased risk, a
change from whole-fat to reduced-fat dairy in the 2 trials
identified was associated with either no significant change
over the study period (43) or improved outcomes for some
(but not all) risk factors (44). Both of these trials included
children over a wide range of ages, including puberty.
This wide range makes it difficult to determine whether
differences exist prior to puberty.
Within the studies investigating cardiometabolic risk,
7 reported data on blood lipids, of which only 3 investigated
lipid ratios [TC:HDL cholesterol (44, 51) or apoB:apoA1 ratios (44, 73)]. Although trials in this review noted a
decrease in LDL cholesterol when changing from wholefat to reduced-fat dairy (43, 44), the lack of change to the
ratio of TC:HDL cholesterol (44) [Hendrie and Golley (43)
did not report any ratios] suggests there could have been
no or only minimal change to overall cardiovascular risk
based on serum lipids. However, the ratio of apoB:apoA-1
was observed to fall by Villalpando et al. (44) in a change
from whole-fat to skim milk, representing a more extreme
change in dairy fat intake. Changes in energy intake from
milk were compensated for in these children by increased
intakes of tortillas (low glycemic index, high-fiber, limetreated whole cornmeal pancakes), which might have also
affected lipid profiles. Potential limitations of this study
included nonrandomized groups and differing provision of
liquid milk to the skim milk group, whereas the reduced-fat
and whole-fat groups received powdered milk.
Chronic inflammation and oxidative stress are linked
with a range of disease processes, including cardiovascular
disease, diabetes, certain types of cancer, and cognitive
impairment (82). This review found no evidence that
the consumption of whole-fat dairy foods increases inflammation biomarkers. Indeed, higher concentrations of
biomarkers of dairy fat consumption were associated with
lower chronic inflammation, as represented by IL-6 (74).
In overweight, but not normal-weight adolescents, dairy fat
intake biomarkers were associated with beneficial higher
adiponectin concentrations (74). Adiponectin is considered
to play an important role in glucose and lipid metabolism,
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In prospective studies, adults with HbA1c values above the
median had reported higher intakes of whole-fat dairy at
14 y (∼450 g/wk higher, P = 0.013), compared with those
below the median, in the Amsterdam Growth and Health
Longitudinal Study (53). No significant associations with
intakes of any type of dairy were observed for HOMA-IR
from early to late adolescence in the Raine Study (51). In
a cross-sectional study of children and adolescents from
lower socioeconomic suburbs of Buenos Aires, category
of whole-fat milk intake (≤1 glass/d, 2–3 glasses/d, and
≥4 glasses/d, glass volume not defined) was inversely
associated with HOMA-IR in adjusted models (β = −0.135,
P < 0.05), and with fasting insulin (uU/mL) in unadjusted
models (from lowest to highest, respectively, 4.59 ± 4.79,
3.61 ± 3.49, 2.34 ± 1.33; P = 0.03; adjusted model only
performed for HOMA-IR) (60). Reduced-fat milk intake was
not considered in this study, because reduced-fat milk was
more expensive and therefore considered by the authors
to be unobtainable by most study participants. Although
confounders were included in the adjusted model (physical
activity, television viewing, sugar-sweetened beverage intake,
parental education, sex, age, along with HDL cholesterol and
systolic blood pressure), it could be hard to separate the
effects of socioeconomic status, which could be particularly
relevant in this population: ∼16% of the families did not
have a refrigerator, and 9% had a dirt floor in their home.
In a relatively higher socioeconomic status group of Swedish
adolescents, dairy fat–related fatty acids measured in either
serum or diet were not significantly associated with serum
insulin concentrations (73).

Australian Raine Study, data-driven factor analysis identified
a distinct “Western” dietary pattern in the adolescent cohort,
consisting of high intakes of whole-fat dairy along with
takeaway foods, red meats, and processed meats (87). Strong
associations with other unhealthy dietary or lifestyle factors
could increase the likelihood of residual or unmeasured
confounding (10). In addition, a lower saturated fat intake
could result in changes to other aspects of the diet to maintain
energy balance. This could be detrimental to health, depending on the replacement foods. Replacement of saturated
fat with refined carbohydrate or ω-6 polyunsaturated fats
(without also increasing ω-3 fats) is proposed to lead to
an increased risk of cardiovascular disease or death (88–
90). In the 2 controlled trials we identified, decreasing dairy
fat did not occur in isolation—Villalpando et al. (44) noted
tortilla consumption increased, and Hendrie and Golley (43)
noted that carbohydrate intake as a percentage of total energy
increased.
Dietary biomarkers
Only 2 studies in our review used established biomarkers
for dairy fat intake. The low use of biomarkers is likely
due to subject burden and cost. Wang et al. (74) found
that serum phospholipids 15:0 and 17:0 were inversely
associated with inflammation and oxidative stress markers
in adolescents, but for most of the risk factors only in those
who were overweight. The authors suggest that the effects
were more noticeable in those who were overweight because
excess adiposity is known to be associated with low-grade
inflammation. Samuelson et al. (73) showed a difference
dependent on which type of biomarker was considered:
15:0 was inversely correlated with the apoB:apoA-1 ratio
in boys, whereas trans-16:1n–7 was positively associated
with the apoB:apoA-1 ratio. Given that 15:0 and trans16:1n–7 are both considered representative for the same
exposure (i.e., dairy fat), the discrepancy in direction of
the associations observed suggests either a lack of biological
plausibility or potential limitations in the use of these
biomarkers to represent dairy fat intake. In addition, growth
and maturation can also influence the utility of specific
biomarkers in studies of children and adolescents (91).
Comparison with the adult literature
The results from our review are similar to previous reviews in
adult populations. A systematic review and meta-analysis of
adult cohort studies reported that whole-fat dairy intake was
not significantly associated with changes in body weight (92).
In addition, a meta-analysis of randomized studies in adults
found no detrimental effects of whole-fat dairy, with changes
in cardiometabolic risk factors similar for both reduced-fat
and whole-fat dairy interventions (79). A 2018 systematic
review of prospective studies investigated the association
between circulating dairy fat biomarkers at baseline and risk
of cardiovascular events during follow-up. The review found
15:0 was associated with lower risk of heart failure but was not
associated with total cardiovascular disease, coronary heart
disease, or stroke. Those with higher intakes of 17:0 had a
Whole- or reduced-fat dairy in children 19
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with insulin-sensitizing and anti-inflammatory properties
(83). Although most studies investigating cardiometabolic
outcomes included BMI in their modeling, few investigated
weight as a potential effect modifier. This could affect
associations observed, because adipose tissue is an active
endocrine organ, and children with excess adipose tissue
could have differing responses to dairy fat.
Results of studies could also be affected by the processing
of the dairy consumed. In our review, 2 studies reported
a net detrimental effect of whole-fat dairy: the Villalpando
et al. (44) trial in Mexico, which reported that changing to
skim dairy improved LDL cholesterol and the apoB:apoA-1
ratio (although HDL cholesterol decreased); and the Wong
et al. (71) observational study in Canada, which reported
a positive association with non-HDL cholesterol (although
HDL cholesterol and cholesterol ratios were not reported).
The Mexican Villalpando et al. (44) trial supplied milks
with different processing techniques applied—the skim milk
was provided in ready-to-consume liquid form, whereas the
whole-fat and 2% fat milks were supplied in powdered form.
Powdering, along with ultra-high-temperature processes,
can alter the composition of the milk slightly, affecting
milk properties and fat content (84). Fat-soluble vitamins
in dairy are reduced by removing dairy fat. However, in
the Villalpando et al. (44) trial the reduced-fat and skim
milks were subsequently fortified, including with fat-soluble
vitamins A and D. In this study, the reduced-fat milk had
almost 25% more vitamin A than the normal whole-fat milk,
adding an additional point of difference beyond fat content.
Fortification with vitamin A is also required for reduced-fat
or skim milk in Canada, with vitamin D fortification required
for all milk. This addition of removed fat-soluble vitamins
does not occur in some other countries, such as Australia, and
could partially contribute to differences observed between
studies.
Bovine feeding practices also differ between countries,
resulting in variations in the fatty acid composition of dairy.
Cows fed a diet based on organic grass and legumes produce
milk with higher concentrations of ω-3 and conjugated
linoleic acid compared with cows fed a conventional diet
higher in grain (85). Most dairy cows on US farms are
fed in this conventional manner, in contrast to cows in
Australia, Argentina, and the United Kingdom, which are
predominantly grass fed. However, our results showed that
beneficial associations with dairy fat were observed in a range
of countries with differing feeding practices, including from
Australia, Argentina, Italy, Sweden, and the United Kingdom
along with Canada and the United States (Tables 1 and 2).
From the existing evidence, our ability to assess causality
is extremely limited. Randomized controlled trials provide
a robust design for providing causal evidence, but we only
identified 1 in this area. Residual confounding is inevitably a
problem in observational studies. One issue with an exposure
such as dairy fat is that animal fat intake is very strongly
associated with an unhealthy lifestyle in certain Western
countries (e.g., United States), but not necessarily in others,
such as some developing countries (86). For example, in the

lower risk of cardiovascular disease, whereas no significant
associations were observed with trans-16:1n–7.

Potential for publication bias
In systematic reviews, publication bias generally refers to
the underreporting of trials that did not find a significant
difference. Bias is said to occur if the results of published
studies systematically differ from the results of unpublished
studies. We did not specifically search trial registries and
other sources to identify nonpublished studies. However, we
observed that just under half of our studies reported limited
or no significant differences, suggesting that publication bias
due to insignificant results is unlikely to have a major impact
on our findings.
Generalizability
The subject groups in the studies reviewed covered wide
ranges in terms of age and location. Because studies only
included healthy subjects, results cannot be generalized to
children who are suffering from disease. Although many
studies adjusted for sex in statistical models, most did not
present associations separately for boys and girls. Of those
studies that did report separate results for boys and girls,
almost all reported differing associations in terms of the
strength of associations (45, 48, 51, 59, 73). Notably, these
studies included children with age ranges into the teens,
indicating that puberty and hormone differences could play
a role in the relation between dairy fat intake and health
outcomes. Apart from potential sex differences in adolescent
cohorts, no trends were observed between different age
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Recommendations and conclusion
This review has highlighted the lack of randomized controlled trials investigating health effects of whole- compared
with reduced-fat dairy in children. This type of study design
is considered to provide the most robust and reliable evidence
because it minimizes biases in the assessment of dietary
intakes as well as the risk of confounding inherent in
observational studies (96). Cross-sectional studies provided
the bulk of evidence in this review, and care must be taken
when interpreting results given the potential for reverse
causation. For example, parents of a child who is overweight
might prefer to provide reduced-fat dairy rather than wholefat dairy, with the intention of reducing overall caloric intake.
The only previous randomized controlled trial investigated
BMI and waist circumference as indirect markers of adiposity
(43), but did not directly assess body composition. To date,
there have also been no published randomized controlled
trials in children investigating body composition through
DXA or whole-body densitometry. Future studies using
these body composition assessments would provide a more
precise measure of adiposity than BMI. In addition, few
pediatric studies have used biomarkers of dairy fat intake
to assess exposure to whole-fat dairy intake, which would
help validate dietary intake data. Observational studies might
also benefit from using nutrient density–adjusted exposure
variables (i.e., dairy intake as percentage of total energy,
rather than servings or grams per day). This would help
minimize biases affecting the dietary assessment, including
over- and underreporting (97). It would also enable studies
of substitution effects that provide estimates of differential
health effects of replacing specific dairy food calories with
other food calories (98). Thorough exploration of these
factors is important in the context of population health.
At the time of writing, we are aware of 2 pediatric
randomized controlled trials investigating dairy fat that are
currently underway, 1 in Australia, the Milky Way Study
(99), and 1 in Canada, the Cow Milk Fat Obesity Prevention
Trial (100). Further, consideration also needs to be given
to the type of dairy product consumed, to questions of
production or processing—for example, whether cows are
predominantly grass fed or grain fed—and to potential effect
modification by sex, puberty status, and adiposity category.
Obesity in childhood is described as a complex and
growing public health problem, increasing risk of chronic
disease, disability, and psychosocial consequences (101). In
the context of cardiovascular disease risk, abnormalities in
lipoprotein metabolism are noted as among the key factors
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Quality of adiposity measures
Many studies in this review relied on BMI as a measure of
adiposity. Although BMI is cheap and easy to measure, it
is a measure of weight relative to height, rather than excess
body fat. It does not take into consideration fat mass and fatfree mass. A study comparing BMI with fat mass and fatfree mass from DXA in healthy 5 to 18-y-olds found that
the accuracy of BMI as a surrogate measure of adiposity in
children varies according to age, gender, degree of adiposity,
and ethnicity (93). Both weight gain and an increase in BMI
over time are part of a normal, healthy development for
children. BMI z-score accounts for age and gender, relative
to an external reference, and is considered appropriate for use
as a marker of adiposity on a single occasion (94). However,
it has limitations for measuring change, because the withinchild variability over time depends on the child’s initial level
and the reference standards used. Due to the periods of
dynamic changes over childhood growth, the stability of BMI
or BMI percentiles can be more appropriate (94). In addition,
BMI z-score has been proposed to be a poor metric to use
in children with severe obesity, because it is only weakly
associated with other measures of body fatness (95). Despite
these potential limitations, our review showed that results
did not differ by markers of adiposity, with whole-fat dairy
showing either beneficial or no associations with BMI, BMI
z-score, or body composition measures (DXA or BIA).

groups and outcomes. Adiposity could be another potential effect modifier. In the only study that stratified by
weight status (74), beneficial associations between dairy fat
biomarkers and inflammatory and oxidative stress markers
were observed in overweight, but not in normal-weight
adolescents. This suggests that potential beneficial effects of
dairy fat might be more noticeable in children who suffer
from obesity-associated low-grade chronic inflammation.
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in atherogenesis, representing ∼50% of the populationattributable risk of developing cardiovascular disease (102).
Even small differences in dietary effects are likely to have
a meaningful impact at the population level, so it is
important that our dietary guidelines around dairy fat intake
in childhood are based on evidence from well-designed
controlled studies.
Overall, our review suggests that dietary recommendations to limit consumption of whole-fat dairy products in
children are not supported by the existing, relatively limited
evidence in the areas of adiposity or cardiometabolic disease.
However, it must be noted that the current body of evidence
on this topic has many limitations, including a lack of good
quality randomized controlled trials directly comparing the
impact of consuming diets rich in whole-fat compared with
reduced-fat dairy foods.
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